Denali Therapeutics shares owned by Rockefeller Capital Management
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Rockefeller Capital Management
from 13F filings
Historical chart of Rockefeller Capital Management investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Rockefeller Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $16k | 1.1k | 14.52 |
| 2023-06-30 | $262k | 8.9k | 29.51 |
| 2023-03-31 | $200k | 8.7k | 22.94 |
| 2022-12-31 | $193k | 9.9k | 19.61 |
| 2022-09-30 | $282k | 12k | 23.81 |
| 2022-06-30 | $330k | 11k | 29.40 |
| 2022-03-31 | $632k | 20k | 32.14 |
| 2021-12-31 | $733k | 17k | 44.55 |
| 2021-09-30 | $743k | 15k | 50.20 |
| 2021-06-30 | $562k | 7.2k | 77.98 |
| 2021-03-31 | $249k | 4.4k | 56.61 |
| 2020-12-31 | $209k | 2.5k | 83.60 |
| 2020-09-30 | $89k | 2.5k | 35.60 |
More positions owned by Rockefeller Capital Management
View all positions for Rockefeller Capital Management